NEPHROS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
NEPHROS, INC. (NEPH) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$1.57 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2024-03-15
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$654.00K.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was -$182.00K.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$433.00K.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$306.00K.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$1.57M.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$7.11M.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$3.87M.
- NEPHROS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$3.18M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$836.00K derived: sum of 2 quarters · filed 2024-03-15 | -$1.27M derived: sum of 3 quarters · filed 2024-03-15 | -$1.57M 10-K · filed 2024-03-15 |
| 2023-09-30 | -$182.00K 10-Q · filed 2023-11-08 | -$615.00K derived: sum of 2 quarters · filed 2023-11-08 | -$921.00K 10-Q · filed 2023-11-08 | -$1.77M derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-06-30 | -$433.00K 10-Q · filed 2023-11-08 | -$739.00K 10-Q · filed 2023-08-09 | -$1.59M derived: sum of 3 quarters · filed 2024-03-15 | -$4.74M derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-03-31 | -$306.00K 10-Q · filed 2023-11-08 | -$1.15M derived: sum of 2 quarters · filed 2024-03-15 | -$4.31M derived: sum of 3 quarters · filed 2024-03-15 | -$5.45M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | -$848.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$4.00M derived: sum of 2 quarters · filed 2024-03-15 | -$5.14M derived: sum of 3 quarters · filed 2024-03-15 | -$7.11M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$3.15M 10-Q · filed 2023-11-08 | -$4.29M derived: sum of 2 quarters · filed 2023-11-08 | -$6.26M 10-Q · filed 2023-11-08 | -$7.30M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$1.14M 10-Q · filed 2023-11-08 | -$3.10M 10-Q · filed 2023-08-09 | -$4.15M derived: sum of 3 quarters · filed 2023-11-08 | -$5.31M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-03-31 | -$1.97M 10-Q · filed 2023-11-08 | -$3.01M derived: sum of 2 quarters · filed 2023-11-08 | -$4.17M derived: sum of 3 quarters · filed 2023-11-08 | -$5.30M derived: sum of 4 quarters · filed 2023-11-08 |
| 2021-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$2.20M derived: sum of 2 quarters · filed 2023-03-23 | -$3.33M derived: sum of 3 quarters · filed 2023-03-23 | -$3.87M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$1.16M 10-Q · filed 2022-11-15 | -$2.29M derived: sum of 2 quarters · filed 2022-11-15 | -$2.83M 10-Q · filed 2022-11-15 | |
| 2021-06-30 | -$1.13M 10-Q · filed 2022-11-15 | -$1.66M derived: sum of 2 quarters · filed 2022-11-15 | ||
| 2021-03-31 | -$537.00K 10-Q · filed 2022-11-15 | |||
| 2019-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$888.00K derived: sum of 2 quarters · filed 2020-02-27 | -$1.83M derived: sum of 3 quarters · filed 2020-02-27 | -$3.18M 10-K · filed 2020-02-27 |
| 2019-09-30 | -$744.00K 10-Q · filed 2019-11-06 | -$1.69M derived: sum of 2 quarters · filed 2019-11-06 | -$3.04M 10-Q · filed 2019-11-06 | -$3.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | -$942.00K 10-Q · filed 2019-11-06 | -$2.29M 10-Q · filed 2019-08-07 | -$2.96M derived: sum of 3 quarters · filed 2020-02-27 | -$3.50M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | -$1.35M 10-Q · filed 2019-11-06 | -$2.01M derived: sum of 2 quarters · filed 2020-02-27 | -$2.56M derived: sum of 3 quarters · filed 2020-02-27 | -$3.25M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | -$664.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$1.21M derived: sum of 2 quarters · filed 2020-02-27 | -$1.90M derived: sum of 3 quarters · filed 2020-02-27 | -$3.33M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$550.00K 10-Q · filed 2019-11-06 | -$1.23M derived: sum of 2 quarters · filed 2019-11-06 | -$2.66M 10-Q · filed 2019-11-06 | -$1.37M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | -$682.00K 10-Q · filed 2019-11-06 | -$2.11M 10-Q · filed 2019-08-07 | -$822.00K derived: sum of 3 quarters · filed 2019-11-06 | -$1.45M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-03-31 | -$1.43M 10-Q · filed 2019-11-06 | -$140.00K derived: sum of 2 quarters · filed 2019-11-06 | -$772.00K derived: sum of 3 quarters · filed 2019-11-06 | |
| 2017-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $657.00K derived: sum of 2 quarters · filed 2019-03-12 | -$809.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$632.00K 10-Q · filed 2018-11-08 | -$2.10M 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | -$3.03M 10-K · filed 2017-03-20 | |||
| 2015-12-31 | -$3.09M 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |